Hematology analyzers are widely used in hospitals, research & academic institutes, clinical testing laboratories and other diagnostic centers for blood cell counting and blood testing. Rising prevalence of blood disorders such as anemia, blood cancers and hematological conditions is propelling the demand for high throughput hematology analyzers. Advancements in flow cytometry, digitization and artificial intelligence are fueling technological upgrades in hematology analyzers, improving accuracy and efficiency of diagnosis. The global Hematology Market is estimated to be valued at US$ 2.19 Bn in 2023 and is expected to exhibit a CAGR of 6.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The rapid improvement in diagnostic technologies is one of the key trends driving the hematology market growth. Technological advancements such as introduction of artificial intelligence, machine learning and high-speed cell analysis are helping hematology analyzers to provide more accurate results in less time. For instance, Sysmex XN hematology analyzers use artificial intelligence-based imaging to capture high-resolution digital images of cells and AI-powered analysis to detect subtle variations in cells and flag abnormalities for review. This is resulting in more efficient diagnosis of various blood-related conditions. With continued innovations, hematology analyzers are becoming more automated, compact and easy to use, increasing their adoption in diagnostics labs as well as point-of-care settings.
Segment Analysis
The global hematology market is dominated by the instruments sub-segment owing to the high adoption of advanced hematology analyzers worldwide that helps cater to the growing needs of diagnostics and healthcare industry. Hematology analyzers provide rapid and accurate blood analysis that aids in quicker diagnosis and treatment of blood-related disorders. Rising prevalence of blood disorders and increasing demand for automated hematology analysis is fueling the growth of the instruments sub-segment.
Key Takeaways
The global Hematology Market Share is expected to witness high growth over the forecast period of 2023 to 2030. The hematology market size for the year 2024 is projected to reach US$ 2.19 Bn registering a CAGR of 6.9% during the forecast period.
Regional analysis: North America dominates the global hematology market and is expected to maintain its dominance over the forecast period. This can be attributed to the rising incidence of blood disorders, availability of advanced hematology instruments, and presence of major players in the region. The Asia Pacific region is anticipated to witness the fastest growth during the forecast period owing to growing healthcare expenditure, rapidly improving healthcare infrastructure, and increasing patient population.
Key players operating in the hematology market are Shaanxi Undersun Biomedtech Co., Ltd., Tocris Bioscience (Bio-Techne Corporation), BioOrigin, Nature's Sunshine Products, Inc., Organic Herb Inc., Damin Foodstuff (Zhangzhou) Co., Ltd., Nutra Green Biotechnology Co., Ltd., Xian Yuensun Biological Technology Co., Ltd., Guangxi Yiyuan Biotechnology Co., Ltd., Changsha Heking Bio-Tech Co., Ltd., Hangzhou Botanical Technology Co., Ltd., Novoherb Technologies, Jiangsu Changhai Food Additive Co., Ltd., Xian Sost Biological Science & Technology Co., Ltd., Xi'an Plant Bio-Engineering Co., Ltd.
For more insights, read- https://www.ukwebwire.com/hematology-market-trends-size-and-share-analysis/
For more details on the report, Read- https://careersplay.com/unlocking-of-the-symphony-of-cell-signals-navigating-the-landscape
Comments
0 comment